Effect of single intravenous doses of histamine2-receptor antagonists on volume and pH of gastric acid secretions in critically ill patients

Keith M. Olsen, F. Charles Hiller, Bruce H. Ackerman, Kelly Crisp-Landwehr, Gerardo S. San Pedro

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The effects of single doses of cimetidine, famotidine, and ranitidine on gastric acid and fluid secretions in 12 critically ill, mechanically ventilated patients were evaluated in a prospective, randomized, crossover, single-blind trial. Each patient received an intravenous dose of cimetidine 300 mg, famotidine 20 mg, or ranitidine 50 mg diluted in 50 mL of normal saline and infused over 30 minutes. Each agent was administered in crossover fashion on consecutive days after the pH returned to baseline. Analysis of gastric fluids and pH measurements were determined from gastric samples collected every 15 minutes. Cimetidine, famotidine, and ranitidine treatment resulted in significant increases in gastric pH and decreased fluid production and total aspirated fluid volume. Famotidine maintained a gastric pH ≥4.0 for a mean duration of 16.5 ± 4.1 hours, significantly longer (P < 0.01) than cimetidine (2.3 ± 1.3 hours) or ranitidine (4.9 ± 0.8 hours). The percent of pH readings ≥4.0 was significantly (P < 0.01) greater for famotidine (88.0%) compared with cimetidine (38.5%) and ranitidine (55.6%). In critically ill patients given a single intravenous dose, famotidine suppressed acid secretion to a greater degree and for longer time periods than with either cimetidine or ranitidine.

Original languageEnglish (US)
Pages (from-to)756-768
Number of pages13
JournalCurrent Therapeutic Research
Volume56
Issue number8
DOIs
StatePublished - Aug 1995

Fingerprint

Famotidine
Ranitidine
Gastric Acid
Cimetidine
Critical Illness
Stomach
Fluids and Secretions
Reading
Acids

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Effect of single intravenous doses of histamine2-receptor antagonists on volume and pH of gastric acid secretions in critically ill patients. / Olsen, Keith M.; Hiller, F. Charles; Ackerman, Bruce H.; Crisp-Landwehr, Kelly; San Pedro, Gerardo S.

In: Current Therapeutic Research, Vol. 56, No. 8, 08.1995, p. 756-768.

Research output: Contribution to journalArticle

Olsen, Keith M. ; Hiller, F. Charles ; Ackerman, Bruce H. ; Crisp-Landwehr, Kelly ; San Pedro, Gerardo S. / Effect of single intravenous doses of histamine2-receptor antagonists on volume and pH of gastric acid secretions in critically ill patients. In: Current Therapeutic Research. 1995 ; Vol. 56, No. 8. pp. 756-768.
@article{2a465ef8353d4c0789d1548bdfa63730,
title = "Effect of single intravenous doses of histamine2-receptor antagonists on volume and pH of gastric acid secretions in critically ill patients",
abstract = "The effects of single doses of cimetidine, famotidine, and ranitidine on gastric acid and fluid secretions in 12 critically ill, mechanically ventilated patients were evaluated in a prospective, randomized, crossover, single-blind trial. Each patient received an intravenous dose of cimetidine 300 mg, famotidine 20 mg, or ranitidine 50 mg diluted in 50 mL of normal saline and infused over 30 minutes. Each agent was administered in crossover fashion on consecutive days after the pH returned to baseline. Analysis of gastric fluids and pH measurements were determined from gastric samples collected every 15 minutes. Cimetidine, famotidine, and ranitidine treatment resulted in significant increases in gastric pH and decreased fluid production and total aspirated fluid volume. Famotidine maintained a gastric pH ≥4.0 for a mean duration of 16.5 ± 4.1 hours, significantly longer (P < 0.01) than cimetidine (2.3 ± 1.3 hours) or ranitidine (4.9 ± 0.8 hours). The percent of pH readings ≥4.0 was significantly (P < 0.01) greater for famotidine (88.0{\%}) compared with cimetidine (38.5{\%}) and ranitidine (55.6{\%}). In critically ill patients given a single intravenous dose, famotidine suppressed acid secretion to a greater degree and for longer time periods than with either cimetidine or ranitidine.",
author = "Olsen, {Keith M.} and Hiller, {F. Charles} and Ackerman, {Bruce H.} and Kelly Crisp-Landwehr and {San Pedro}, {Gerardo S.}",
year = "1995",
month = "8",
doi = "10.1016/0011-393X(95)85059-7",
language = "English (US)",
volume = "56",
pages = "756--768",
journal = "Current Therapeutic Research - Clinical and Experimental",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "8",

}

TY - JOUR

T1 - Effect of single intravenous doses of histamine2-receptor antagonists on volume and pH of gastric acid secretions in critically ill patients

AU - Olsen, Keith M.

AU - Hiller, F. Charles

AU - Ackerman, Bruce H.

AU - Crisp-Landwehr, Kelly

AU - San Pedro, Gerardo S.

PY - 1995/8

Y1 - 1995/8

N2 - The effects of single doses of cimetidine, famotidine, and ranitidine on gastric acid and fluid secretions in 12 critically ill, mechanically ventilated patients were evaluated in a prospective, randomized, crossover, single-blind trial. Each patient received an intravenous dose of cimetidine 300 mg, famotidine 20 mg, or ranitidine 50 mg diluted in 50 mL of normal saline and infused over 30 minutes. Each agent was administered in crossover fashion on consecutive days after the pH returned to baseline. Analysis of gastric fluids and pH measurements were determined from gastric samples collected every 15 minutes. Cimetidine, famotidine, and ranitidine treatment resulted in significant increases in gastric pH and decreased fluid production and total aspirated fluid volume. Famotidine maintained a gastric pH ≥4.0 for a mean duration of 16.5 ± 4.1 hours, significantly longer (P < 0.01) than cimetidine (2.3 ± 1.3 hours) or ranitidine (4.9 ± 0.8 hours). The percent of pH readings ≥4.0 was significantly (P < 0.01) greater for famotidine (88.0%) compared with cimetidine (38.5%) and ranitidine (55.6%). In critically ill patients given a single intravenous dose, famotidine suppressed acid secretion to a greater degree and for longer time periods than with either cimetidine or ranitidine.

AB - The effects of single doses of cimetidine, famotidine, and ranitidine on gastric acid and fluid secretions in 12 critically ill, mechanically ventilated patients were evaluated in a prospective, randomized, crossover, single-blind trial. Each patient received an intravenous dose of cimetidine 300 mg, famotidine 20 mg, or ranitidine 50 mg diluted in 50 mL of normal saline and infused over 30 minutes. Each agent was administered in crossover fashion on consecutive days after the pH returned to baseline. Analysis of gastric fluids and pH measurements were determined from gastric samples collected every 15 minutes. Cimetidine, famotidine, and ranitidine treatment resulted in significant increases in gastric pH and decreased fluid production and total aspirated fluid volume. Famotidine maintained a gastric pH ≥4.0 for a mean duration of 16.5 ± 4.1 hours, significantly longer (P < 0.01) than cimetidine (2.3 ± 1.3 hours) or ranitidine (4.9 ± 0.8 hours). The percent of pH readings ≥4.0 was significantly (P < 0.01) greater for famotidine (88.0%) compared with cimetidine (38.5%) and ranitidine (55.6%). In critically ill patients given a single intravenous dose, famotidine suppressed acid secretion to a greater degree and for longer time periods than with either cimetidine or ranitidine.

UR - http://www.scopus.com/inward/record.url?scp=0029080084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029080084&partnerID=8YFLogxK

U2 - 10.1016/0011-393X(95)85059-7

DO - 10.1016/0011-393X(95)85059-7

M3 - Article

AN - SCOPUS:0029080084

VL - 56

SP - 756

EP - 768

JO - Current Therapeutic Research - Clinical and Experimental

JF - Current Therapeutic Research - Clinical and Experimental

SN - 0011-393X

IS - 8

ER -